ReviewCNS drugs2018
Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis.
Bernard M J UitdehaagPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this paperpooled ittrialcites it
ReviewCNS drugs2018
Bernard M J UitdehaagPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.